Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. WuXi AppTec Co., Ltd.
  6. News
  7. Summary
    603259   CNE1000031K4

WUXI APPTEC CO., LTD.

(603259)
  Report
End-of-day quote. End-of-day quote Shanghai Stock Exchange - 09/17
152.4 CNY   +5.72%
08/25WUXI APPTEC : Investor Day - Industry Trend and Company Strategy
PU
08/25WUXI APPTEC : Investor Day - Financial Performance
PU
08/25WUXI APPTEC : Investor Day - WuXi Biology
PU
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Engine Biosciences Pte. Ltd. announced that it has received SGD 57 million in funding from a group of investors

05/26/2021 EDT

Engine Biosciences Pte. Ltd. announced that it has raised SGD 57 million in a round of funding led by new investor Polaris Partners on May 26, 2021. The transaction included participation from new investors The Invus Group, LLC, existing investors 6 Dimensions Capital, L.P., WuXi AppTec Co., Ltd. (SHSE:603259), Danhua Capital, EDB Investments Pte. Ltd., Baidu Ventures, Vectr Ventures Limited, Goodman Capital Limited, WI Harper Group, Nest.Bio Ventures and and world’s premier institutional investors. The company has raised SGD 70 million in funding till date. As part of the transaction Amy Schulman from Polaris Partners, had joined the company's board.


ę S&P Capital IQ 2021
All news about WUXI APPTEC CO., LTD.
08/25WUXI APPTEC : Investor Day - Industry Trend and Company Strategy
PU
08/25WUXI APPTEC : Investor Day - Financial Performance
PU
08/25WUXI APPTEC : Investor Day - WuXi Biology
PU
08/25WUXI APPTEC : Investor Day - WuXi Chemistry
PU
08/25WUXI APPTEC : Investor Day - WuXi Testing
PU
08/13WUXI APPTEC : H1 Profit Surges 56% on Strong Revenue
MT
08/12WuXi AppTec Co., Ltd. Announces Earnings Results for the Half Year Ended June 30, 2021
CI
08/12WUXI APPTEC : Reports Strong 2021 Interim Results
PU
08/03WUXI APPTEC : STA Completes Acquisition of Bristol Myers Squibb Manufacturing Facility in ..
PU
07/26WUXI APPTEC : Inside information - proposed disposal of a shares by a shareholder
PU
More news
Analyst Recommendations on WUXI APPTEC CO., LTD.
More recommendations
Financials
Sales 2021 22 600 M 3 492 M 3 492 M
Net income 2021 4 418 M 683 M 683 M
Net cash 2021 11 569 M 1 788 M 1 788 M
P/E ratio 2021 99,2x
Yield 2021 0,26%
Capitalization 449 B 69 407 M 69 352 M
EV / Sales 2021 19,3x
EV / Sales 2022 14,4x
Nbr of Employees 28 542
Free-Float 56,7%
Chart WUXI APPTEC CO., LTD.
Duration : Period :
WuXi AppTec Co., Ltd. Technical Analysis Chart | 603259 | CNE1000031K4 | MarketScreener
Technical analysis trends WUXI APPTEC CO., LTD.
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 21
Last Close Price 152,40 CNY
Average target price 185,83 CNY
Spread / Average Target 21,9%
EPS Revisions
Managers and Directors
Min Zhang Chen Co-Chief Executive Officer
Qing Yang Co-CEO, Executive Director & Executive VP
Ge Li Chairman & President
Ellis Chu Chief Financial Officer & Senior Vice President
Harry He Chairman-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
WUXI APPTEC CO., LTD.35.75%69 407
GILEAD SCIENCES, INC.23.12%88 970
BIONTECH SE318.73%81 878
REGENERON PHARMACEUTICALS33.91%66 632
VERTEX PHARMACEUTICALS-21.38%48 168
BEIGENE, LTD.50.36%37 076